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Background: Portal triad clamping (PTC) is the most commonly used method of achieving vascular
control during liver resection. However, the efficacy and safety of PTC, compared with those of other
methods of vascular control, are uncertain.
Methods: A systematic review was conducted to identify randomized controlled trials (RCTs) comparing
PTC with other methods of vascular control during liver resection. Endpoints included in-hospital mor-
tality, need for transfusion, number of complications and length of hospital stay. Meta-analyses were
performed using a random-effects model.
Results: Ten RCTs were identified; these included a total of 820 patients. No statistically significant
differences between PTC and other forms of vascular control in liver resection were demonstrated.
Conclusions: There is no evidence, on the basis of this meta-analysis of RCTs, of any difference
between PTC and other forms of vascular control in liver resection.
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Introduction
Haemorrhage has historically represented one of the major risks
in liver resection and the amount of blood lost is proportionally
linked to operative morbidity and mortality.1–3 Moreover, blood
transfusion is associated with increased tumour recurrence after
hepatectomy for both hepatocellular cancer and colorectal
metastases.4–6 This effect seems to be present with both autologous
and allogeneic blood products.7 In the 1970s, major liver resection
was associated with operative mortality rates of > 20% and a
significant proportion of these deaths resulted from intraopera-
tive haemorrhage.8 Over the last three decades, there have been
significant improvements in the results of liver resection. Opera-
tive mortality is < 5% in most modern series9–12 and > 90% of
all hepatectomies are performed without transfusion.13–15 These
improvements reflect better understanding of liver anatomy,16
improved surgical techniques (including the maintenance of
low central venous pressure),17,18 more sophisticated equipment,
advances in perioperative care and superior methods of anaesthe-
sia.19 Portal triad clamping (PTC) has traditionally been the pre-
ferred method of vascular control, but, more recently, other means
of vascular control during hepatic resection have been described.
These include selective hepatic vascular exclusion (SHVE),20 total
hepatic vascular exclusion (THVE)21,22 and hepatic vascular exclu-
sion with caval flow preservation.23,24 Specialized techniques for
liver mobilization, such as the hanging manoeuvre, combined
with the various types of vascular control have also been
reported.25
Although both intermittent and continuous PTC have been
widely used, 60 min of continuous clamping has been shown to
be safe under normothermic conditions, provided there is no
pre-existing parenchymal liver disease rendering the organ more
susceptible to ischaemia.26,27 More recently, it has been suggested
that intermittent PTC can be detrimental to outcome through
damage to the liver parenchyma during multiple reperfusion epi-
sodes, associated with bleeding during reperfusion and a longer
operating time.28 Ischaemic preconditioning consists of a short
period (e.g. 10 min) of clamping, followed by reperfusion (often
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10 min) applied prior to the prolonged clamping.14 Although the
possible benefit of preconditioning was first seen in models of
coronary occlusion,29 a recent meta-analysis failed to show any
benefit of the technique in liver resection.30 The aim of this sys-
tematic review and meta-analysis was to review the efficacy and
safety of PTC compared with those of other forms of vascular
control in patients undergoing liver resection.
Materials and methods
Literature search
A systematic literature search was independently conducted by
two authors (AJR and VWTL). The following electronic databases
were searched: MEDLINE (1950–2011); EMBASE (1974–2011);
the Cochrane Controlled Trials Register, and the Science Citation
Index. Combinations of medical subject headings (MeSH), as well
as keywords, were used, including the following terms: ‘inflow
occlusion’; ‘hepatic vascular exclusion’; ‘vascular occlusion’;
‘portal triad occlusion’; ‘Pringle manoeuvre’; ‘hepatectomy’; ‘liver
resection’; ‘hemi-hepatectomy’; ‘hepatic surgery’, and ‘liver
surgery’. The literature search was not restricted by language or
year of publication, but was restricted to human trials. The last
search was performed on 14 October 2011. All the relevant articles
identified were manually searched and independent experts were
contacted in order to retrieve other relevant articles.
Study selection and primary endpoints
Only randomized controlled trials (RCTs) were included in the
review. Studies comparing intermittent or continuous PTC with
other means of vascular control in liver resection with or without
ischaemic preconditioning were included. Studies describing pae-
diatric liver resections, procedures related to transplantation or
laparoscopic liver resection were excluded, as were animal trials.
Studies comparing continuous with intermittent PTC were
excluded.
The primary endpoints analysed were in-hospital mortality and
number of patients receiving a blood transfusion. The secondary
endpoints analysed were intraoperative blood loss, postoperative
liver failure, total number of complications and operative time.
Total number of complications was a composite endpoint that
referred to incidences of myocardial infarction, chest infection,
pulmonary embolus, bile leak and intra-abdominal collections.
Studies with insufficient data relating to the defined primary or
secondary outcomes were excluded. The reporting was conducted
in accordance with the PRISMA criteria.31 Two reviewers indepen-
dently performed study selection (AJR and VWTL) and disagree-
ments were resolved by discussion with the third author (JML).
The methodological quality of studies was assessed to establish
whether each study fulfilled the following criteria: use of adequate
sequence generation; allocation concealment; use of blinding;
addressing of incomplete data, and freedom from selective report-
ing and other biases.
Statistical analysis
Meta-analyses were performed using RevMan 5.0 (Review
Manager Version 5.0; Cochrane Collaboration, Oxford, UK).
Primary outcomes were expressed as odds ratios (ORs) with 95%
confidence intervals (95% CIs) derived by the mean difference
(MD) method with a random-effects model.32 The Mantel–
Haenzsel (M–H) method was used for dichotomous outcomes and
the inverse variance method was used for continuous outcomes.
Heterogeneity was assessed using Cochran’s Q statistic and an I2
statistic, where values of  25% were considered to indicate low
heterogeneity and values of  75% were taken to indicate high
heterogeneity.33 Forest plots were constructed and P-values of
< 0.05 were considered to indicate statistical significance. Funnel
plots were constructed to assess for potential publication bias.
Results
Description of studies
Ten studies34–43 met the predefined criteria for inclusion in the
meta-analysis; these are summarized in Table 1. The search strat-
egy is shown in Fig. 1. The studies originated from China, France,
Hong Kong, Germany, Greece and Italy. Outcomes for a total of
820 patients reported in the RCTs were available for meta-analysis.
These included 409 and 411 patients undergoing hepatectomy
with PTC and SHVE, respectively. The mean standard error of
the mean (SEM) of the mean ages was 52.3 3.3 years in the PTC
group and 51.4 3.3 years in the SHVE group. Methods of PTC
and the control SHVE technique with which they were compared
varied substantially across the studies analysed (Table 2). Methods
of SHVE ranged from no vascular control at all, to complete
vascular isolation of the liver achieved using both infra- and
suprahepatic inferior vena cava clamping or clamping of all
hepatic veins. The PTC technique was also variably continuous or
intermittent with or without ischaemic preconditioning.
Study quality
Statistically significant heterogeneity was observed in analyses of
blood loss (I2 = 92%), operative times (I2 = 84%), postoperative
stays (I2 = 94%) and transfusion requirements (I2 = 80%), but
not in analyses of mortality (I2 = 0%), postoperative liver
failure (I2 = 0%) or incidences of postoperative complications
(I2 = 29%). Given the small number of studies reporting data
appropriate for analysis, funnel plot analysis could only be used to
explore bias44,45 in mortality (Fig. 2a), transfusion requirements
(Fig. 2b) and incidences of postoperative complications (Fig. 2c).
No significant funnel plot asymmetry was observed in these analy-
ses. A risk for bias diagram is shown in Fig. 3. Only two studies
reported the method of randomization.38,40
Mortality
There were six deaths in the PTC group and five in the SHVE
group. Data were available in all 10 studies analysed and there was
356 HPB
HPB 2012, 14, 355–364 © 2012 International Hepato-Pancreato-Biliary Association
no difference in the risk for death between the two groups (OR
1.15, 95% CI 0.38–3.50) (Fig. 4a).
Transfusion
Data on the number of patients receiving blood transfusions were
available for nine RCTs relating to 780 patients (Fig. 4b). There
was no difference in the number of patients receiving blood trans-
fusion between the PTC and SHVE groups (OR 1.01, 95% CI
0.42–2.42).
Secondary endpoints
There was no difference between the PTC and SHVE groups in the
incidence of operative blood loss (MD 57.92, 95% CI - 180.77 to
296.61) (Fig. 5a), operative time (MD 0.04, 95% CI - 18.15 to
18.22) (Fig. 5b), total postoperative complications (OR 0.93, 95%
CI 0.64–1.37) (Fig. 5c), postoperative stay (MD – 0.54, 95% CI
- 4.89 to 3.81) (Fig. 5d) or postoperative liver failure (OR 0.86,
95% CI 0.28–2.66) (Fig. 5e).
Discussion
This systematic review addressed the question of whether PTC is
superior to other methods of vascular control in liver resection.
The main outcome measures were in-hospital mortality and the
number of patients requiring transfusion. The meta-analysis of
Table 1 Summary of randomized controlled trials comparing portal triad clamping (PTC) with control methods of selective hepatic vascular
exclusion (SHVE)
Trial Location of trial Year Total
participants,
n
PTC
patients,
n
PTC
patients,
age, yearsa
PTC
patients,
male : female
SHVE
patients,
n
SHVE
patients
age, yearsa
SHVE
patients,
male : female
Belghiti et al.41 Paris, France 1996 52 24 43.0 8 : 16 28 48.0 13 : 15
Capussotti et al. 38 Turin, Italy 2006 126 63 63.8 NS 63 64.9 NS
Chen et al. 42 Wuhan, China 2006 118 58 41.5 51 : 7 60 39.7 53 : 7
Chouker et al. 43 Munich, Germany 2004 34 19 59.4 13 : 6 15 57.7 7 : 7
Liang et al. 39 Chengdu, China 2009 80 40 49.4 27 : 13 40 49.6 31 : 9
Man et al. 36 Hong Kong 1997 100 50 59.0 40 : 10 50 52.5 41 : 9
Man et al. 37 Hong Kong 2003 40 20 52b 14 : 6 20 48b 15 : 5
Fu et al. 40 Shanghai, China 2010 120 60 48.6 46 : 14 60 49.3 41 : 19
Smyrniotis et al. 35 Athens, Greece 2003 110 55 62b 44 : 11 55 61b 43 : 12
Smyrniotis et al. 34 Athens, Greece 2003 40 20 59b 15 : 5 20 61b 16 : 4
aMean value unless otherwise indicated.
bMedian value.
NS not stated.
Figure 1 Flow chart showing the search strategy used to identify studies
HPB 357
HPB 2012, 14, 355–364 © 2012 International Hepato-Pancreato-Biliary Association
RCTs showed no significant differences between the methods in
the main or secondary endpoints analysed.
Blood loss, along with extent of resection and presence of cir-
rhosis, is one of the major determinants of outcome after liver
resection.46 Loss of > 600 ml of blood has been associated with
rising morbidity and mortality. The proportional relationship
among blood loss, transfusion requirement and mortality is mir-
rored in other surgical procedures.47–49 Therefore, manoeuvres to
limit blood loss might be expected to improve outcomes. The
results of liver resection have improved over time,8 coincidently
with reductions in intraoperative blood loss and requirements for
transfusion.12–14,50 Portal triad clamping was the earliest method
reported to limit haemorrhage during liver resection and has been
described as effective.4,26,51 Nevertheless, there is still concern that
the routine use of PTC may in fact be detrimental, particularly in
cases with significant pre-existing parenchymal liver damage.
Although it is well tolerated in the majority of patients, PTC may
lead to significant increases in mean arterial pressure and systemic
vascular resistance with a decrease in cardiac index.52 Portal triad
clamping has also been linked with splanchnic congestion and
bacterial translocation from the gut. The main advantage of PTC
is that it is simple and applicable in many situations, although it
should be avoided in the resection of lesions involving the hepatic
veins or inferior vena cava and in patients with right heart failure
and pulmonary hypertension.53 A number of techniques to limit
the physiological impact of PTC have been described. These
include the intermittent application of PTC and ischaemic pre-
conditioning. Intermittent PTC has been associated with higher
blood loss than continuous PTC, but a reduced incidence of post-
operative liver failure, particularly in the presence of cirrhosis.54
Ischaemic preconditioning involves a short period of liver
ischaemia prior to transection with PTC in place. The technique is
believed to augment the liver’s tolerance to prolonged ischaemia.
Although ischaemic preconditioning has been widely studied with
contradictory results,43,55 a meta-analysis has not shown the tech-
nique to make significant differences in mortality, blood loss or
liver failure, although significant improvements in length of
intensive care unit and hospital stay have been demonstrated.30
There was considerable variation in the precise form of PTC used
in the studies included in this analysis. Continuous and intermit-
tent PTC and ischaemic preconditioning were each variously
used.
The techniques compared with PTC in the studies included in
this meta-analysis were variable, ranging from no vascular control
to THVE. Generally, the more complete the vascular isolation of
the liver, the better the control of haemorrhage, but greater
ischaemic insult to the organ causes greater congestion of the
viscera and cardiac stress. Total hepatic vascular exclusion involves
total inflow and outflow occlusion of the liver,21,56 and can be
combined with aortic clamping57 and hypothermic perfusion of
the liver.58,59 The major problem with THVE is that it results in an
unpredictable fall in cardiac output that may cause the patient to
become unable to tolerate the procedure.21,53,56,60 This technique is
therefore commonly reserved for resection involving the inferior
vena cava or hepatic veins and can be used to facilitate the recon-
struction of these structures.13,53,61–63 Hemihepatic vascular clamp-
ing (HHVC) is a lesser form of vascular isolation that can be
combined with clamping the hepatic veins ipsilateral to the resec-
tion and was popularized by Makuuchi et al.20,64 It is theoretically
advantageous because it avoids ischaemia to the future liver
remnant and splanchnic congestion and possibly affords greater
haemodynamic stability. The major disadvantage of HHVC con-
cerns the risk for bleeding from the perfused remnant during
resection.53,65 The technique may be contra-indicated for tumours
Table 2 Details of portal triad clamping (PTC) and selective hepatic vascular exclusion (SHVE) with which it was compared
Trial Details of PTC Details of SHVE
Belghiti et al.41 NS PTC combined with infra- and suprahepatic IVC clamp –
HVE
Capussotti et al. 38 Intermittent: 15 min PTC and 5 min release; no IP Extraparenchymal control of HA and PV ipsilateral to
resection
Chen et al. 42 NS PTC combined with infrahepatic IVC clamp – MTHVE
Chouker et al. 43 Continuous; no IP NVC
Liang et al. 39 Intermittent: 20 min PTC and 5 min release; no IP Extraparenchymal control of HA and PV ipsilateral to
resection
Man et al. 36 Intermittent: 20 min PTC and 5 min release to maximum of
120 min; no IP
NVC; extent of extraparenchymal control of HA and PV not
stated
Man et al. 37 Intermittent: 20 min PTC and 5 min release to maximum of
120 min; no IP
NVC; extent of extraparenchymal control of HA and PV not
stated
Fu et al. 40 Continuous if < 30 min then intermittent: 15 min PTC and
5 min release; no IP
Extraparenchymal control of HA and PV ipsilateral to
resection
Smyrniotis et al. 35 Continuous; IP used in last 20 patients PTC combined with clamping of all hepatic veins – THVE
Smyrniotis et al. 34 Continuous; no IP PTC combined with clamping of all hepatic veins – THVE
HA, hepatic artery; HVE, hepatic vascular exclusion; IP; ischaemic preconditioning; IVC, inferior vena cava; MTHVE, modified technique of hepatic
vascular exclusion; NS, not stated; NVC, no vascular control; PV, portal vein; THVE, total hepatic vascular exclusion.
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approaching the hilum or where there are dense adhesions.20,53,66
Methods of segmental vascular occlusion have been described and
may be useful for small peripheral tumours in cirrhotic livers, but
were not used in the studies analysed.67,68 The variety of tech-
niques of both PTC and SHVE are likely to contribute to the
significant heterogeneity observed in this meta-analysis.
Many patients undergoing resection for colorectal metastasis
and hepatocellular carcinoma have liver damage induced by pre-
operative chemotherapy69 and cirrhosis, respectively. The more
complete vascular isolation of the liver may reduce blood loss
during transection, but also increases the ischaemic insult to the
organ. Although the liver is relatively resistant to periods of warm
ischaemia,70 it is vulnerable to anoxic conditions and may be more
severely vulnerable if it has been chronically damaged by either
cirrhosis or chemotherapy. It may be that PTC induces only
partial ischaemia of the liver as a result of hepatic back-perfusion
from the inferior vena cava and venous anastomoses between the
human splanchnic and systemic circulations.71 Reperfusion injury
can lead to further parenchymal damage from Kupffer cell activa-
tion, the production of free radicals, neutrophil activation and
micro-circulatory disturbances.28,72–74 A number of studies have
established that  90 min of complete PTC is safe in normal
livers.26,43,75,76 Nonetheless, many surgeons will not clamp the
inflow continuously for > 45 min because of concern about occult
liver damage and most resections can be accomplished within this
timeframe. Intuitively, there is a balance to be struck between the
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Figure 2 Outcomes in portal triad clamping and selective hepatic
vascular exclusion for (a) postoperative mortality, (b) number of
patients requiring transfusion and (c) the incidence of postoperative
complications. SE, standard error; OR, odds ratio
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Figure 3 Summary of risk for bias: authors' judgements about each
risk for bias item for each study included
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risk associated with excessive haemorrhage and the liver ischaemia
induced in order to prevent it. The lack of difference between PTC
and the methods of vascular control used in the studies reviewed
here may reflect the relative counterbalancing effect of these two
imperatives in each study protocol.
Despite the inclusion of newly available data from recent and
relatively large RCTs,39,40 the results of this meta-analysis are
broadly consistent with those of previous meta-analyses77,78 and
the Cochrane review30 of the topic. Although the analysis includes
only RCTs, they are of variable quality and provide little informa-
tion about potential sources of bias. Moreover, the number of
trials in the analysis is small and each contributes a small number
of patients. Meta-analysis is primarily a tool for overcoming the
problem of the reduced statistical power afforded by studies with
small sample sizes.79 The failure of the current meta-analysis to
detect a difference in outcomes between the PTC and SHVE
groups naturally raises the question of whether this reflects a lack
of power or a false negative result arising from other causes. Sig-
nificant heterogeneity was observed in the meta-analytic statistical
measures. This heterogeneity may be attributable to differences in
the patients (such as in numbers with benign lesions or underly-
ing liver disease), methods of transection of the liver parenchyma,
outcome assessment and quality of reporting. Most significantly,
the techniques of both PTC and the control method with which it
was compared in each RCT were variable. This heterogeneity may
obscure an important treatment effect. In order to initiate a
change in practice, it is imperative that further RCTs not only
address a priori the question of power, but also reflect contempo-
raneous liver surgery in the design of their experimental and
control arms.
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Figure 4 Forest plots illustrating the meta-analysis of outcomes in patients undergoing liver resection with portal triad clamping (PTC) or
selective hepatic vascular exclusion (SHVE) for (a) postoperative mortality and (b) number of patients requiring transfusion. M–H, Mantel–
Haenszel test; 95% CI, 95% confidence interval
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Figure 5 Forest plots illustrating the meta-analysis of outcomes in patients undergoing liver resection with portal triad clamping (PTC)
or selective hepatic vascular exclusion (SHVE) for (a) intraoperative blood loss, (b) operative time, (c) total postoperative complications,
(d) postoperative stay and (e) postoperative liver failure. M–H, Mantel–Haenszel test; 95% CI, 95% confidence interval
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